Medicaid drugs

Health Care Financing Review

Volumn 25, Issue 3, 2004, Pages 1-4

  Poisal, John A ^a,b  

^a The Centers for Medicare Medicaid Services (CMS)   (United States)

^b Center for Medicare and Medicaid Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; DRUG COST; DRUG DELIVERY SYSTEM; DRUG PROGRAM; HEALTH PROGRAM; MEDICAID; PRESCRIPTION; REVIEW;

COST CONTROL; DRUG COSTS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MEDICAID; UNITED STATES;

EID: 2642542558     PISSN: 01958631     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (2)

1. Danzon, P. and Furukawa, M.: Prices and Availability of Pharmaceuticals: Evidence From Nine Countries. Health Affairs: w3-521-w3-536, October, 29 2003. Internet address: http://content.healthaffairs.org/cgi/reprint/hlthaff.w3.521v1.pdf (Accessed March 2004.)
2. National Pharmaceutical Council, Inc. Pharmaceutical Benefits Under State Medical Assistance Programs 2001. Reston, VA. 2002. Internet address: http://www.npcnow.org/resources/PDFs/medicaid2002/2002_Introduction.pdf (Accessed March 2004.)